Programme and Speakers Presentations

Wednesday 8 November 2017

Registration opens

INGID workshop: The specialist nurse: a vital link between patients and doctors

  • The Need for Nurses in the PID World (PDF)Nurse Carla Duff
  • The Role of Specialised Nurse in PID – Nurse Rosalind Fisher
  • Update on the European Guidelines for the administration of Immunoglobulin – Nurse Dorothea Grosse Kreul

Welcome Session “PIDs: not only a paediatric issue”
Welcome – Mrs Jose Drabwell and Prof Steve Holland
A Historical Perspective on Primary Immunodeficiencies (PDF)Prof Helen Chapel
• Importance of adult diagnosis and treatment: case study examples – Dr Siobhan Burns: Gain-of-function mutations, CVID
• PIDs in adulthood: an epidemiological perspective – Prof Charlotte Cunningham Rundles
• Why do we need transition care? Physician Perspective (PDF) – Dr Nizar Mahlaoui; Patient Perspective (PDF)Ms Rachel Hammond

Welcome Reception

Thursday 9 November 2017

Exhibition, Poster section and Registration

Opening session including keynote address
Chair: Prof Bobby Gaspar
• Welcome remarks – Mr Johan Prevot
• Congress Opening Address – Mrs Jose Drabwell
• Keynote lecture: Why should we treat Primary Immunodeficiencies at all? – Prof Steven Holland

Session 1: Screening for PIDs: early detection for optimal care
Chair: Prof Alain Fischer
• The importance of newborn screening for PIDs: TRECs/KRECs and beyond – Prof Mirjam van der Burg
• An Update from the French National SCID Newborn Screening pilot programme – Dr Marie Audrain
• Focus on Asia – Middle East: the role of neonatal screening – Dr Maytham Husain
The preventive role of pre-implantation diagnosis – Pro’s and Con’s (PDF)Ms Alison Lashwood

Coffee Break

Session 2: PID care and ethical issues– what can be said, what should be said?
Chair: Prof Bobby Gaspar
• Presentation of different scenarios
• Panel discussion: Dr James Taylor, Prof Alain Fischer, Mrs Jose Drabwell, Mr Bruce Lim, Nurse Carla Duff
• Interactive Discussion – ALL

Lunch & Poster Walk

Session 3: Regional clinical priorities in PID treatments
Chairs: Mrs Marcia Boyle and Prof Surjit Singh
EU Regional Priorities (PDF)Prof Isabelle Meyts
• USA Regional Priorities – Prof Charlotte Cunningham-Rundles
Asian Regional Priorities (PDF)Dr Adli Ali
• Middle East Regional Priorities – Dr Maytham Husain; Disseminated BCGitis in PID – Dr Daifulah Al Zahrani
• LATAM Regional Priorities – Dr Alejandra King
• African Regional Priorities – Dr James Chipeta

Coffee Break

Session 4 – PIDs and dermatological issues
Chair: Dr Suleiman Al-Hammadi
• Genetic predispositions to dermatological manifestations in PIDs – Dr Bodo Grimbacher
• Recognizing dermatological issues to accelerate diagnosis and treatment of PIDs – Dr Arti Nanda
• Management of chronic fungal and parasitic skin infections in PIDs – Prof Olivier Lortholary
Patient testimony: Living with CGD (PDF)Mr Andrea Gressani

Congress dinner: 
Al Sahara Desert Fortress

Friday 10 November 2017

Exhibition, Poster section and Registration

Session 5: Focus on Immune Dysregulations
Chair: Prof Oksenhendler
The cross-road between PIDs and allergy (PDF)Prof António Condino Neto
• Granulomas in PIDs: clinical management and key considerations – Prof Martin Van Hagen
PIDs and Autoimmune diseases – treatment options (PDF)Prof Alain Fischer
• HLH – genetic predisposition and management – Dr Despina Moshous

Coffee Break

Session 6 – Diseases specific session
Chair: Prof Olivier Hermine
• Combined Immunodeficiencies – Prof Aziz Bousfiha
• Antibody deficiencies – Dr Waleed Al Herz
• Innate immunodeficiencies – Dr Jordan Orange

Lunch and Poster Walk – (Prayer room available during this time)

Lunch session: Oral presentations (poster winners)
Chairs: Mrs Jose Drabwell and Prof Aziz Bousfiha
1 – Homozigous TCF3 mutation is associated with severe hypogammaglobulinemia and acute lymphoblastic leukemia (PDF) –  Dr Ben Ali-Meriem
2 – Alone or add-on? Inhaling nebulised immunoglobulins: 18 months of real life experience (PDF) – Dr N. Brodszki
3 – Case series report of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: a single institution study at children’s hospital 1, Ho Chi Minh, Vietnam – Dr N. Phan

Session 7: PIDs and Transplant Advances – where are we going?
Chair: Prof Bobby Gaspar
• HSCT – advances in conditioning and graft engineering. Experience from the Middle East Region – Prof Saleh Al Muhsen
• Gene therapy – where are we now? – Prof Alessandro Aiuti
Gene editing: precision medicine for PIDs (PDF)Dr Matthew Porteus
Patient testimony: Living with Hyper IgE Syndrome, a fascinating journey. (PDF) – Ms Eva Varga

Coffee Break

Session 8: Novel treatments for Primary Immunodeficiencies
Chair: Prof António Condino Neto
• Targeted PID Treatment: The role of monoclonal antibodies – Prof Steve Holland
Biosimilars: understanding their use in PIDs and the implications (PDF)Prof Eric Oksenhendler
• Clinical use of specific inhibitors in the treatment of PIDs – Prof Olivier Hermine
An overview of latest IG therapy advances (PDF)Prof Klaus Warnatz

Closure talk: PIDs & Immunology, driving the future of Science? – Prof Bobby Gaspar